Back |
home / stock / epgny / epgny message board
Subject | By | Source | When |
---|---|---|---|
DGAP-News Epigenomics AG: Clinical study conducted in the | wagner | investorshub | 03/05/2014 11:14:59 AM |
GERMAN Results positiv | wagner | investorshub | 03/05/2014 9:15:47 AM |
26th march | harry74nrw | investorshub | 03/02/2014 10:49:30 AM |
News, Short Squeeze, Breakout and More Instantly...
Epigenomics Ag S/Adr Company Name:
EPGNY Stock Symbol:
OTCMKTS Market:
Under the primary base case analysis, annual m SEPT9 screening resulted in more Quality-adjusted-life-years gained (QALYG), CRC cases averted and CRC deaths averted than both annual FIT screening and Cologuard ® every three years, albeit at a higher colonoscopy referral rate ...
Dover, Delaware--(Newsfile Corp. - June 17, 2020) - Encode Ideas, L.P. Initiates Research on Epigenomics AG (Xetra: ECX.DE) (FSE: ECX) (OTC: EPGNF). The full research publication is available here and available on our website at www.encodelp.com . A summary follows: Encode Ideas, L.P., a h...
- Adherence rates and screening intervals recognized as decisive elements of successful screening strategies - BERLIN, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”), today reported on micro-simulation model results indicating th...